Intraocular inflammatory cytokines in patients with neovascular age-related macular degeneration before and after initiation of intravitreal injection of anti-VEGF inhibitor
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Intraocular inflammatory cytokines in patients with neovascular age-related macular degeneration before and after initiation of intravitreal injection of anti-VEGF inhibitor ; volume:8 ; number:1 ; day:18 ; month:1 ; year:2018 ; pages:1-10 ; date:12.2018
Scientific reports ; 8, Heft 1 (18.1.2018), 1-10, 12.2018
- Keyword
-
Augenheilkunde
Augenkrankheit
- Creator
-
Sato, Tomohito
- Contributor
-
Takeuchi, Masaru
Karasawa, Yoko
Enoki, Toshio
Ito, Masataka
SpringerLink (Online service)
- DOI
-
10.1038/s41598-018-19594-6
- URN
-
urn:nbn:de:1111-2018041217352
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sato, Tomohito
- Takeuchi, Masaru
- Karasawa, Yoko
- Enoki, Toshio
- Ito, Masataka
- SpringerLink (Online service)
Other Objects (12)
The effect of vitreomacular interface in neovascular age-related macular degeneration treated with intravitreal injection of anti-VEGF
Retrospective analysis of OCT parameters after intravitreal anti-VEGF inhibitors in neovascular AMD patients in a real-world setting
Atrophy of retinal vessels in neovascular age-related macular degeneration following long-term treatment with 20 intravitreal anti-VEGF injections
Long term results of patients with neovascular age-related macular degeneration switched from other anti-VEGF agents to intravitreal Aflibercept
Choroidal remodeling following different anti-VEGF therapies in neovascular AMD
Long-term outcomes of intravitreal anti-VEGF therapies in patients affected by neovascular age-related macular degeneration: a real-life study
Prevalence and implications of the presence of intraocular silicone oil droplets in patients treated with intravitreal injections of anti-VEGF
Guidance for anti-VEGF intravitreal injections during the COVID-19 pandemic
Case report: heart failure related to intravitreal injection of anti-VEGF
Bacterial endophthalmitis following anti-VEGF intravitreal injections: a retrospective case series
Hydrophilic Lens Opacification after Intravitreal Anti-VEGF Injections: A Case Series
Fibrosis in age-related neovascular macular degeneration in the anti-VEGF era
The effect of vitreomacular interface in neovascular age-related macular degeneration treated with intravitreal injection of anti-VEGF
Retrospective analysis of OCT parameters after intravitreal anti-VEGF inhibitors in neovascular AMD patients in a real-world setting
Atrophy of retinal vessels in neovascular age-related macular degeneration following long-term treatment with 20 intravitreal anti-VEGF injections
Long term results of patients with neovascular age-related macular degeneration switched from other anti-VEGF agents to intravitreal Aflibercept
Choroidal remodeling following different anti-VEGF therapies in neovascular AMD
Long-term outcomes of intravitreal anti-VEGF therapies in patients affected by neovascular age-related macular degeneration: a real-life study
Prevalence and implications of the presence of intraocular silicone oil droplets in patients treated with intravitreal injections of anti-VEGF
Guidance for anti-VEGF intravitreal injections during the COVID-19 pandemic
Case report: heart failure related to intravitreal injection of anti-VEGF
Bacterial endophthalmitis following anti-VEGF intravitreal injections: a retrospective case series
Hydrophilic Lens Opacification after Intravitreal Anti-VEGF Injections: A Case Series
Fibrosis in age-related neovascular macular degeneration in the anti-VEGF era
The effect of vitreomacular interface in neovascular age-related macular degeneration treated with intravitreal injection of anti-VEGF
Retrospective analysis of OCT parameters after intravitreal anti-VEGF inhibitors in neovascular AMD patients in a real-world setting
Atrophy of retinal vessels in neovascular age-related macular degeneration following long-term treatment with 20 intravitreal anti-VEGF injections
Long term results of patients with neovascular age-related macular degeneration switched from other anti-VEGF agents to intravitreal Aflibercept
Choroidal remodeling following different anti-VEGF therapies in neovascular AMD
Long-term outcomes of intravitreal anti-VEGF therapies in patients affected by neovascular age-related macular degeneration: a real-life study
Prevalence and implications of the presence of intraocular silicone oil droplets in patients treated with intravitreal injections of anti-VEGF
Guidance for anti-VEGF intravitreal injections during the COVID-19 pandemic
Case report: heart failure related to intravitreal injection of anti-VEGF
Bacterial endophthalmitis following anti-VEGF intravitreal injections: a retrospective case series
Hydrophilic Lens Opacification after Intravitreal Anti-VEGF Injections: A Case Series